Skip to main content
Ian Sarembock, MD, Cardiology, Cincinnati, OH

Ian J. Sarembock MD MB,ChB

Adult Congenital Heart Disease, Interventional Cardiology, Cardiac Critical Care


Ohio Heart & Vascular Center

Join to View Full Profile
  • RetiredMontgomery, OHIOCincinnati, OH 45237

  • Phone+1 513-206-1167

Dr. Sarembock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Cardiovascular Disease, 1986 - 1988
  • University of Cape Town Faculty of Medicine
    University of Cape Town Faculty of MedicineClass of 1975

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2007 - 2024
  • VA State Medical License
    VA State Medical License 1988 - 2008
  • TN State Medical License
    TN State Medical License 2002 - 2003
  • Cardiovascular Disease
    National Board of Physicians and Surgeons Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Whos Who in Medicine and Healthcare Marquis Whos Who
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Transcatheter Mitral-Valve Repair in Patients with Heart Failure  
    JoAnn Lindenfeld, Saibal Kar, Michael J Mack, Samir R Kapadia, Gregg W Stone, Ian J Sarembock, William T Abraham, Andreas Brieke, David J Cohen, Steven O Marx, Brian W..., The New England Journal of Medicine

Grant Support

  • Selectins Role In Vascular Injury In Gene-TargetedNational Heart, Lung, And Blood Institute2003–2004
  • Selectins Role In Vascular Injury In Gene-Targeted MiceNational Heart, Lung, And Blood Institute2001–2002
  • Novel Adenosine A2A Agonists In Vascular ProtectionNational Heart, Lung, And Blood Institute2000
  • Effect Of Thrombin Inhibition By Hirudin On AngioplastyNational Heart, Lung, And Blood Institute1991–1993

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: